Empagliflozin vs Levodopa

## Empagliflozin vs Levodopa: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Levodopa**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Levodopa — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Levodopa — C9H11NO4.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Levodopa — 197.1880 g/mol.

**Type**: Empagliflozin — Small molecule; Levodopa — Small molecule.